Groundbreaking Pancreatic Cancer Drug Approved by FDA: What We Know

Groundbreaking pancreatic cancer drug approved by FDA: What we know

The Food and Drug Administration has approved a landmark new drug for advanced pancreatic cancer, one of the deadliest types of the disease.

Groundbreaking pancreatic cancer drug approved by FDA; Roswell Park played key role in trial

Doctors at Roswell Park Comprehensive Cancer Center in Buffalo played a key role in the FDA approval of a groundbreaking new drug for pancreatic cancer.

New hope for pancreatic cancer patients after FDA approves drug to improve survival

Pancreatic cancer is among the deadliest forms, largely because detection is difficult before malignancy spreads to other organs